Table 1

Effect of preincubation with salicylate on AA toxicity in HepG2 cells.

AdditionPercent Toxicity
ABCD
E47 (buffer) E47 (Sal) C34 (buffer) C34 (Sal)
None2.8  ± 2.15.8  ± 2.59.5  ± 3.09.0  ± 4.2
Salicylate (5 mM)5.2  ± 3.05.5  ± 1.911.8  ± 1.56.3  ± 1.0
Salicylate (10 mM)3.0  ± 0.04.3  ± 2.610.8  ± 2.96.5  ± 2.4
AA (30 μM)21.3  ± 4.61-150 25.0  ± 8.41-150 12.0  ± 2.711.8  ± 1.0
AA (60 μM)37.0  ± 5.11-150 42.0  ± 4.41-150 12.3  ± 2.916.5  ± 1.3
AA 30 μM + Sal (5 mM)43.5  ± 9.01-160 53.3  ± 3.51-160 7.8  ± 3.011.8  ± 1.0
AA 60 μM + Sal (5 mM)60.8  ± 2.21-160 65.5  ± 3.11-160 16.0  ± 6.28.1  ± 4.0
AA 30 μM + Sal (10 mM)61.5  ± 7.41-160 68.3  ± 6.21-160 11.0  ± 4.511.0  ± 5.0
AA 60 μM + Sal (10 mM)75.0  ± 10.01-160 82.5  ± 6.51-160 10.5  ± 5.313.3  ± 0.5

E47 cells (A, B) or C34 cells (C, D) were preincubated with buffer (A, C) or with 10 mM sodium salicylate (B, D) for 24 hours. The medium was removed, the cells washed, and the indicated additions were made to all cells, followed by viability assays (Trypan Blue uptake) after 24 h of incubation.

    • 1-150 p < 0.05 compared with no addition.n = 4.

    • 1-160 p < 0.05 compared with AA without addition of salicylate. n = 4.